All

Cancer statistics for the year 2020: An overview

Posted on by SGW Content
10
Feb

Jacques Ferlay 1, Murielle Colombet 1, Isabelle Soerjomataram 1, Donald M Parkin 2 3, Marion Piñeros 1, Ariana Znaor 1, Freddie Bray 1
Affiliations Expand
PMID: 33818764 DOI: 10.1002/ijc.33588

Abstract

Our study briefly reviews the data sources and methods used in compiling the International Agency for Research on Cancer (IARC) GLOBOCAN cancer statistics for the year 2020 and summarises the main results. National estimates were calculated based on the best available data on cancer incidence from population-based cancer registries (PBCR) and mortality from the World Health Organization mortality database. Cancer incidence and mortality rates for 2020 by sex and age groups were estimated for 38 cancer sites and 185 countries or territories worldwide. There were an estimated 19.3 million (95% uncertainty interval [UI]: 19.0-19.6 million) new cases of cancer (18.1 million excluding non-melanoma skin cancer) and almost 10.0 million (95% UI: 9.7-10.2 million) deaths from cancer (9.9 million excluding non-melanoma skin cancer) worldwide in 2020. The most commonly diagnosed cancers worldwide were female breast cancer (2.26 million cases), lung (2.21) and prostate cancers (1.41); the most common causes of cancer death were lung (1.79 million deaths), liver (830000) and stomach cancers (769000).

Keywords: GLOBOCAN; cancer; global estimates; incidence; mortality.

PubMed Disclaimer

Similar articles

  • Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

    Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F.Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.PMID: 30350310

  • Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F.Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.PMID: 25220842

  • Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

    Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.PMID: 30207593

  • Cancer in sub-Saharan Africa in 2020: a review of current estimates of the national burden, data gaps, and future needs.

    Bray F, Parkin DM; African Cancer Registry Network.Lancet Oncol. 2022 Jun;23(6):719-728. doi: 10.1016/S1470-2045(22)00270-4. Epub 2022 May 9.PMID: 35550275 Review.

  • World Health Organization Estimates of the Global and Regional Disease Burden of 22 Foodborne Bacterial, Protozoal, and Viral Diseases, 2010: A Data Synthesis.

    Kirk MD, Pires SM, Black RE, Caipo M, Crump JA, Devleesschauwer B, Döpfer D, Fazil A, Fischer-Walker CL, Hald T, Hall AJ, Keddy KH, Lake RJ, Lanata CF, Torgerson PR, Havelaar AH, Angulo FJ.PLoS Med. 2015 Dec 3;12(12):e1001921. doi: 10.1371/journal.pmed.1001921. eCollection 2015 Dec.PMID: 26633831 Free PMC article. Review.
See all similar articles

Cited by

  • Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress.

    Dume B, Licarete E, Banciu M.Mol Ther Nucleic Acids. 2024 Jun 17;35(3):102256. doi: 10.1016/j.omtn.2024.102256. eCollection 2024 Sep 10.PMID: 39045515 Free PMC article. Review.

  • The Influence of Sociodemographic Factors and Clinical Aspects on the Quality of Life of Surgically Treated Patients with Colorectal Cancer.

    Świątkowski F, Lambrinow J, Górnicki T, Jurga M, Chabowski M.Cancer Manag Res. 2024 Sep 27;16:1293-1303. doi: 10.2147/CMAR.S478179. eCollection 2024.PMID: 39355765 Free PMC article.

  • Prospects of Probiotic Adjuvant Drugs in Clinical Treatment.

    Ren Z, Hong Y, Huo Y, Peng L, Lv H, Chen J, Wu Z, Wan C.Nutrients. 2022 Nov 9;14(22):4723. doi: 10.3390/nu14224723.PMID: 36432410 Free PMC article. Review.

  • The deubiquitinating enzyme STAMBP is a newly discovered driver of triple-negative breast cancer progression that maintains RAI14 protein stability.

    Yang Q, Yan D, Zou C, Xue Q, Lin S, Huang Q, Li X, Tang D, Chen X, Liu J.Exp Mol Med. 2022 Nov;54(11):2047-2059. doi: 10.1038/s12276-022-00890-1. Epub 2022 Nov 25.PMID: 36434041 Free PMC article.

  • Relevance of Phytochemical Taste for Anti-Cancer Activity: A Statistical Inquiry.

    Grădinaru TC, Gilca M, Vlad A, Dragoș D.Int J Mol Sci. 2023 Nov 12;24(22):16227. doi: 10.3390/ijms242216227.PMID: 38003415 Free PMC article. Review.
See all “Cited by” articles

References

REFERENCES

  1. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941-1953. https://doi.org/10.1002/ijc.31937.
  2. United Nations, Department of Economic and Social Affairs, Population Division (2019). World Population Prospects 2019, online edition, Revision 1. Accessed July 10, 2019.
  3. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. https://doi.org/10.3322/caac.21660.
  4. Bray F, Colombet M, Ferlay J, et al., eds. Cancer Incidence in Five Continents. Vol 11 (Electronic Version). Lyon: International Agency for Research on Cancer; 2017.
  5. The African Cancer Registry Network http://www.afcrn.org/
SGW Content

Leave a Reply

Your email address will not be published. Required fields are marked *